Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00041704
Status:
COMPLETED
Last Update Posted:
2008-10-20
First Post:
2002-07-12
Brief Title:
The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis FRMC
Sponsor:
Pfizer
Organization:
Pfizer
Organization Data
Organization:
Pfizer
Class:
INDUSTRY
Study ID:
VER002-11
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Pfizer
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Director Clinical Trial Disclosure Group
Old Organization:
Pfizer Inc
Collaborators
| Name | Class |
|---|---|
| Vicuron Pharmaceuticals | INDUSTRY |